相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interplay between α-, β-, and γ-Secretases Determines Biphasic Amyloid-β Protein Level in the Presence of a γ-Secretase Inhibitor
Fernando Ortega et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2012)
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients
Michal J. Figurski et al.
ALZHEIMERS & DEMENTIA (2012)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
β-Amyloid Dynamics in Human Plasma
Yafei Huang et al.
ARCHIVES OF NEUROLOGY (2012)
Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of the Amyloid β Monoclonal Antibody Solanezumab in Japanese and White Patients With Mild to Moderate Alzheimer Disease
Kazunori Uenaka et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers
Gary Tong et al.
CLINICAL THERAPEUTICS (2012)
Stability of amyloid-β peptides in plasma and serum
Mirko Bibl et al.
ELECTROPHORESIS (2012)
Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2
Carla A. Ibrahim-Verbaas et al.
HUMAN GENETICS (2012)
Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer Disease The Honolulu Asia Aging Study
Nilay S. Shah et al.
HYPERTENSION (2012)
Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease
Robert A. Rissman et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
γ-Secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment
Ting Li et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
David A. Wolk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
Eric M. Reiman et al.
LANCET NEUROLOGY (2012)
Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
Antonia M. W. Coppus et al.
NEUROBIOLOGY OF AGING (2012)
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2011)
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
Stephen D. Weigand et al.
ALZHEIMERS & DEMENTIA (2011)
Therapeutic intervention for Alzheimer's disease with γγ-secretase inhibitors: still a viable option?
Bruno P. Imbimbo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline
Kristine Yaffe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment
D. P. Devanand et al.
NEUROLOGY (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease
Imrich Blasko et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Plasma β-Amyloid and Cognitive Decline
Stephanie A. Cosentino et al.
ARCHIVES OF NEUROLOGY (2010)
Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
P. Lewczuk et al.
EXPERIMENTAL NEUROLOGY (2010)
Plasma β-amyloid and duration of Alzheimer's disease in adults with Down syndrome
V. P. Prasher et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
Oskar Hansson et al.
NEUROBIOLOGY OF AGING (2010)
Change in plasma Aβ peptides and onset of dementia in adults with Down syndrome
N. Schupf et al.
NEUROLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
The Relationship of Plasma Aβ Levels to Dementia in Aging Individuals With Down Syndrome
Yasuji Matsuoka et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
Alex E. Roher et al.
ALZHEIMERS & DEMENTIA (2009)
Ten-Year Change in Plasma Amyloid β Levels and Late-Life Cognitive Decline
Olivia I. Okereke et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
Anne M. Fagan et al.
EMBO MOLECULAR MEDICINE (2009)
No correlation between time-linked plasma and CSF Aβ levels
Nathalie Le Bastard et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Association of plasma amyloid β with risk of dementia The prospective Three-City Study
J. -C. Lambert et al.
NEUROLOGY (2009)
Plasma amyloid β-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease
Joseph J. Locascio et al.
ARCHIVES OF NEUROLOGY (2008)
Plasma β amyloid and the risk of Alzheimer disease and dementia in elderly men
Johan Sundelof et al.
ARCHIVES OF NEUROLOGY (2008)
Plasma amyloid ß protein is elevated in late-onset Alzheimer disease families
N. Ertekin-Taner et al.
NEUROLOGY (2008)
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
O. L. Lopez et al.
NEUROLOGY (2008)
Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease
Nicole Schupf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-β after inhibition of γ-secretase
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Safety, tolerability, pharmacokinetics, and Aβ levels after short-term administration of R-flurbiprofen in healthy elderly individuals
Douglas R. Galasko et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Elevated plasma β-amyloid peptide Aβ42 levels, incident dementia, and mortality in Down syndrome
Nicole Schupf et al.
ARCHIVES OF NEUROLOGY (2007)
Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease
Neill R. Graff-Radford et al.
ARCHIVES OF NEUROLOGY (2007)
Plasma Aβ1-40 and Aβ1-42 and the risk of dementia:: a prospective case-cohort study
Marieke van Oijen et al.
LANCET NEUROLOGY (2006)
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
ME Gurol et al.
NEUROLOGY (2006)
Safety, tolerability, and changes in amyloid β concentrations after administration of a γ-secretase inhibitor in volunteers
E Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions
EJ van Dijk et al.
ANNALS OF NEUROLOGY (2004)
Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment
A Assini et al.
NEUROLOGY (2004)
Systemic catabolism of Alzheimer's Aβ40 and Aβ42
J Ghiso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Electrophoretic separation of amyloid β peptides in plasma
P Lewczuk et al.
ELECTROPHORESIS (2004)
Plasma Aβ40 and Aβ42 and Alzheimer's disease -: Relation to age, mortality, and risk
R Mayeux et al.
NEUROLOGY (2003)
Age but not diagnosis is the main predictor of plasma amyloid β-protein levels
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2003)
Serum creatinine levels correlate with plasma amyloid β protein
Z Arvanitakis et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees
N Ertekin-Taner et al.
GENETIC EPIDEMIOLOGY (2001)
Amyloid precursor protein and amyloid β peptide in human platelets -: Role of cyclooxygenase and protein kinase C
DM Skovronsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Elevated plasma amyloid β-peptide 1-42 and onset of dementia in adults with Down syndrome
N Schupf et al.
NEUROSCIENCE LETTERS (2001)
Amyloid-β peptides interact with plasma proteins and erythrocytes:: Implications for their quantitation in plasma
YM Kuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)
分享论文
